Prognostic and diagnostic value of circRNA expression in colorectal carcinoma: a meta-analysis
Open Access
- 19 May 2020
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 20 (1) , 1-8
Abstract
Background: Circular RNAs (circRNAs) are research hotspots in the network of noncoding RNAs in numerous tumours. The purpose of our study was to evaluate the clinicopathological, prognostic and diagnostic value of circRNAs in colorectal cancer.Methods: The PubMed, Cochrane Library, and Web of Science online databases were searched for relevant studies before May 15, 2019. Pooled hazard ratios (HRs) and odds ratios (ORs) with 95% confidence intervals (CIs) were calculated to assess the association between circRNAs expression, and overall survival (OS) and clinical parameters. Pooled sensitivity, specificity, and the area under the curve (AUC) were employed to assess the diagnostic value of circRNAs.Results: A total of 19 studies were enrolled in this meta-analysis, with 11 on clinicopathological parameters, 8 on prognosis and 7 on diagnosis. For clinicopathological and prognostic value, elevated expression of oncogenic circRNAs was correlated with poor clinical parameters (tumor size: OR = 1.769, 95% CI: 1.097–2.852; differentiation grade: OR = 1.743, 95% CI: 1.032–2.946; TNM stage: OR = 3.320, 95% CI: 1.529–7.207; T classification: OR = 3.410, 95% CI: 2.088–5.567; lymph node metastasis: OR = 3.357, 95% CI: 2.160–5.215; distal metastasis: OR = 4.338, 95% CI: 2.503–7.520) and worse prognosis (HR = 2.29, 95% CI: 1.50–3.52). However, elevated expression of tumor-suppressor circRNAs was correlated with better clinical parameters (differentiation grade: OR = 0.453, 95% CI: 0.261–0.787; T classification: OR = 0.553, 95% CI: 0.328–0.934; distal metastasis: OR = 0.196, 95% CI: 0.077–0.498) and favorable prognosis (HR = 0.37, 95% CI: 0.22–0.64). For diagnostic value, the pooled sensitivity, specificity, and AUC were 0.82 (95% CI, 0.75–0.88), 0.72 (95% CI, 0.66–0.78), and 0.82 (95% CI, 0.78–0.85), respectively.Conclusions: These results indicate that circRNAs may be potential biomarkers for the diagnosis and prognosis of colorectal cancer.Keywords
All Related Versions
This publication has 38 references indexed in Scilit:
- Emerging roles of circRNA_001569 targeting miR-145 in the proliferation and invasion of colorectal cancerOncotarget, 2016
- Decreased expression of hsa_circ_001988 in colorectal cancer and its clinical significances.2015
- Regulation of circRNA biogenesisRNA Biology, 2015
- Exon Circularization Requires Canonical Splice SignalsCell Reports, 2015
- A Circuitous Route to Noncoding RNAScience, 2013
- Circular RNAs: splicing's enigma variationsThe EMBO Journal, 2013
- Natural RNA circles function as efficient microRNA spongesNature, 2013
- Circular RNAs are a large class of animal RNAs with regulatory potencyNature, 2013
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- The performance of tests of publication bias and other sample size effects in systematic reviews of diagnostic test accuracy was assessedJournal of Clinical Epidemiology, 2005